Acasti Pharma Inc (ACST)
2.96
-0.07
(-2.31%)
USD |
NASDAQ |
May 03, 16:00
2.875
-0.08
(-2.87%)
After-Hours: 20:00
Acasti Pharma Cash from Financing (Quarterly): 0.00 for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 7.359M |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.109M |
| June 30, 2022 | 0.195M |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 34.68M |
| December 31, 2020 | 19.74M |
| September 30, 2020 | 3.432M |
| June 30, 2020 | 1.635M |
| March 31, 2020 | -0.53M |
| December 31, 2019 | 7.117M |
| September 30, 2019 | 6.562M |
| June 30, 2019 | 0.034M |
| March 31, 2019 | 2.119M |
| December 31, 2018 | 35.59M |
| September 30, 2018 | 0.0449M |
| June 30, 2018 | 7.936M |
| March 31, 2018 | -0.2668M |
| December 31, 2017 | 9.439M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.0165M |
| June 30, 2017 | -0.3237M |
| November 30, 2016 | -0.0004M |
| August 31, 2016 | -0.0015M |
| May 31, 2016 | -0.01M |
| February 29, 2016 | -0.0004M |
| November 30, 2015 | -0.0008M |
| August 31, 2015 | -0.0003M |
| May 31, 2015 | -0.0008M |
| February 28, 2015 | -0.0044M |
| November 30, 2014 | -0.003M |
| August 31, 2014 | -0.0017M |
| May 31, 2014 | 0.0459M |
| February 28, 2014 | 21.55M |
| November 30, 2013 | 0.5026M |
| August 31, 2013 | 0.364M |
| May 31, 2013 | 0.0189M |
| February 28, 2013 | 0.1791M |
| November 30, 2012 | 0.004M |
| August 31, 2012 | 0.0263M |
| May 31, 2012 | 0.0121M |
| February 29, 2012 | 2.288M |
| November 30, 2011 | 7.618M |
| August 31, 2011 | 0.0361M |
| May 31, 2011 | -0.0004M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.53M
Minimum
Mar 2020
34.68M
Maximum
Mar 2021
4.228M
Average
0.034M
Median
Jun 2019
Cash from Financing (Quarterly) Benchmarks
| Aurinia Pharmaceuticals Inc | -5.577M |
| Edesa Biotech Inc | 0.3057M |
| Lexaria Bioscience Corp | 3.453M |
| Xenon Pharmaceuticals Inc | 324.01M |
| ESSA Pharma Inc | 0.1967M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.892M |
| Cash from Investing (Quarterly) | -6.554M |
| Free Cash Flow | -13.57M |
| Free Cash Flow Per Share (Quarterly) | -0.0424 |
| Free Cash Flow Yield | -17.50% |